GTCM
GSK icon

Gyon Technologies Capital Management’s GSK GSK Stock Holding History

Gyon Technologies Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,241
Closed -$149K – 175
2022
Q4 		$149K Sell
4,241
-11,801
-74% -$393K 0.06% 324
2022
Q3 		$472K Buy
16,042
+6,632
+70% +$251K 0.15% 151
2022
Q2 		$512K Buy
9,410
+4,154
+79% +$229K 0.14% 166
2022
Q1 		$286K Buy
+5,256
New +$285K 0.2% 173
2020
Q4 		– Sell
-6,235
Closed -$293K – 388
2020
Q3 		$293K Buy
+6,235
New +$312K 0.23% 160

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Gyon Technologies Capital Management's GSK Position: Q1 2023 in Review

Gyon Technologies Capital Management sold out of GSK (GSK) in Q1 2023, closing a stake of 4,241 shares — an estimated $149K sold.

Gyon Technologies Capital Management first reported a position in GSK in Q3 2020 and held it in 5 quarters. The position peaked at $512K in Q2 2022. 810 funds tracked by Wall St. Rank hold GSK as of Q1 2023.

  • Gyon Technologies Capital Management reported no remaining GSK position as of Q1 2023 after selling out during the quarter.
  • Gyon Technologies Capital Management sold 4,241 GSK shares in Q1 2023, an estimated $149K.
  • Gyon Technologies Capital Management first reported a position in GSK in Q3 2020 and held it in 5 quarters.
  • Gyon Technologies Capital Management's GSK position peaked at $512K in Q2 2022.
  • 810 funds tracked by Wall St. Rank held GSK as of Q1 2023.

Based on Gyon Technologies Capital Management's 13F filing for Q1 2023.